Marex Group’s KalVista Pharmaceuticals KALV Stock Holding History

Marex Group’s Portfolio KALV Stock Details KALV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-20,000	Closed	-$403K	–	1247
2026 Q1	$403K	Buy	+20,000	New	+$322K	﹤0.01%	686

Other funds holding KALV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Marex Group's KALV Position: Q2 2026 in Review

Marex Group sold out of KalVista Pharmaceuticals (KALV) in Q2 2026, closing a stake of 20,000 shares — an estimated $403K sold.

Marex Group first reported a position in KALV in Q1 2026 and held it in 1 quarter. The position peaked at $403K in Q1 2026. 1 fund tracked by Wall St. Rank holds KALV as of Q2 2026.

Marex Group reported no remaining KalVista Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Marex Group sold 20,000 KalVista Pharmaceuticals shares in Q2 2026, an estimated $403K.
Marex Group first reported a position in KalVista Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Marex Group's KalVista Pharmaceuticals position peaked at $403K in Q1 2026.
1 fund tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.